Media
XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development
UCB Partners with Ailux, a Division of XtalPi, on Biologics Al Platform
Ailux, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform
Introducing Ailux by XtalPi
Antibody Engineering & Therapeutics 2025 USA
PEGS Europe 2025
Ailux Announces Posters at American College of Rheumatology (ACR) Convergence 2025
PEGS Boston 2025
Antibody Engineering & Therapeutics 2024 USA
PEGS Europe 2024